Green Thumb Industries Inc. (GTBIF) Reports Q2 Loss, Tops Revenue Estimates

Core Viewpoint - Green Thumb Industries Inc. reported a quarterly loss of $0.01 per share, missing the Zacks Consensus Estimate of $0.04, and showing a decline from earnings of $0.09 per share a year ago, indicating an earnings surprise of -125.00% [1] Financial Performance - The company posted revenues of $293.26 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 4.56%, and showing an increase from year-ago revenues of $280.15 million [2] - Over the last four quarters, Green Thumb Industries has not surpassed consensus EPS estimates, but has topped consensus revenue estimates three times [2] Stock Performance - Green Thumb Industries shares have declined approximately 11.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $285.85 million, and for the current fiscal year, it is $0.15 on revenues of $1.14 billion [7] Industry Outlook - The Medical - Products industry, to which Green Thumb Industries belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of the stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]